Bylvay Capsule, Coated Pellets
Product Images NDC 74528-040

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Bylvay (NDC 74528-040). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Albireo Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Bylvay 01)

FDA Label Image

Figure 1 (Bylvay 02)

Figure 1 (Bylvay 02)
This is a table that seems to be related to the evaluation of scratching score. It includes different scores from 40 to 0 and two different dosages (40mcg/kg/day and 120mcg/kg/day) of a drug called Odevixibat and a placebo. The table also seems to be organized on a monthly basis.*
FDA Label Image

Figure A (Bylvay 03)

FDA Label Image

Figure B (Bylvay 04)

FDA Label Image

Figure C (Bylvay 05)

FDA Label Image

Figure D (Bylvay 06)

FDA Label Image

Principal Display Panel (200 mcg Capsule Bottle Carton)

Principal Display Panel (200 mcg Capsule Bottle Carton)
This is a medication description for odevixibat capsules. Each capsule contains 200mg of the medication. The recommended dosage and prescribing information are not available. The capsules are manufactured for and distributed by Albireo Pharma in Boston, MA. The medication is supposed to be stored at a temperature between 20°C to 25°C, with excursions permitted between 15°C and 30°C. The product has a National Drug Code (NDC) of 74528-020-01.*
FDA Label Image

Principal Display Panel (400 mcg Capsule Bottle Carton)

Principal Display Panel (400 mcg Capsule Bottle Carton)
This is a product description for "Bylvay" capsules with the active ingredient "odevixibat". Each capsule contains 400mcg of odevixibat and is intended for prescription use only. The product is manufactured and distributed by Albireo Pharma, Inc. and the recommended dosage is available in the prescribing information. The product origin is India and it must be stored at a temperature range of 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (between 59°F and 86°F).*
FDA Label Image

Principal Display Panel (600 mcg Capsule Bottle Carton)

Principal Display Panel (600 mcg Capsule Bottle Carton)
This is the label of Y Bylvay oral pellets. Each capsule contains 600mg of odevixibat. The recommended dosage is indicated in the prescribing information. The medication should be stored at a temperature range of 20°C-25°C (68°F-77°F), with excursions between 15°C-30°C (59°F-86°F) permitted. The manufacturer and distributor of the medication is Albireo Pharma, Inc. The NDC number is 74528-060-01.*
FDA Label Image

Principal Display Panel (1,200 mcg Capsule Bottle Carton)

Principal Display Panel (1,200 mcg Capsule Bottle Carton)
This is a description of Bylvay capsules manufactured by Albireo Pharma. It contains 30 capsules of odevixibat with a recommended dosage that should be obtained from the prescribing information. The NDC number is 74528-120-01, and each capsule contains 1,200 meg of odevixibat. The capsules should be stored between 20°C to 25°C (68°F to 77°F), or between 15°C and 30°C (between 59°F and 86°F) with permissible excursions.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.